Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks

Ankara University

Status: Enrolling

Conditions: Patent Ductus Arteriosus After Premature Birth

Treatments: Diagnostic Test: Echocardiography, Doppler ultrasonography, Near-infrared spectroscopy

Study type: Observational

Funder types: Other

Identifiers

NCT05686343

Ankara University-001

Details and patient eligibility

About

To define the characteristics of hemodynamically significant PDA by echocardiography, to investigate the systemic effects of the ductus with cerebral and renal Doppler flow studies, and to determine the oxygen consumption in the cerebral tissue with NIRS in newborns below 32 weeks of age with PDA.

Enrollment: 70 estimated patients

Sex: All

Ages: 1 minute to 7 days old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Born at less than 32 weeks newborns

Exclusion criteria

• Congenital heart disease
• Syndromic and/or major congenital anomaly

Trial design

70 participants in 2 patient groups

Treated

Treatment:

Diagnostic Test: Echocardiography, Doppler ultrasonography, Near-infrared spectroscopy

Untreated

Treatment:

Diagnostic Test: Echocardiography, Doppler ultrasonography, Near-infrared spectroscopy